Squamous Cell Lung C 2012 Cancer 2012thoracicsymposium.org/MeetingProgram/.../GSIIIHammerman.pdfYou +1'd this publicly. Undo File Format: PDF/Adobe Acrobat - Quick View this week. • Squamous cell: TCGA (n=178) in Nature this week ... New targets continue to emerge (ROS, RET) ... of NSCLC (45/733):3% of adenocarcinomas and 20% of squamous carcinomas. WHSC1L1. FGFR1 .... Ponatinib x 2 cycles ...
FWIW, I don't think that offering would send the share price down to 16 or 17. It's not that big of a deal if they do it as an offering. The last offering was absolutely necessary. The fact that it got gobbled up and the shareprice took off from there was a testament to the fact that it was such a strong positive for the company.
I think going about it this way would send a better message to market at this point. Let's not dwell over this for another three days. The company needs money to get into the promised land.